Bimodal Imaging of Tumors via Genetically Engineered <i>Escherichia coli</i>

Although there are emerging innovations of molecular imaging probes to detect and image tumors, most of these molecular dyes and nanoparticles have limitations of low targetability in tumors and fast clearance when administered systemically. In contrast, some bacteria, such as <i>Escherichia c...

Full description

Bibliographic Details
Main Authors: Linlin Zhang, Yuanyuan Wang, Dengjin Li, Liang Wang, Zhenzhou Li, Fei Yan
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/9/1804
_version_ 1797483660691111936
author Linlin Zhang
Yuanyuan Wang
Dengjin Li
Liang Wang
Zhenzhou Li
Fei Yan
author_facet Linlin Zhang
Yuanyuan Wang
Dengjin Li
Liang Wang
Zhenzhou Li
Fei Yan
author_sort Linlin Zhang
collection DOAJ
description Although there are emerging innovations of molecular imaging probes to detect and image tumors, most of these molecular dyes and nanoparticles have limitations of low targetability in tumors and fast clearance when administered systemically. In contrast, some bacteria, such as <i>Escherichia coli MG1655</i>, can selectively proliferate in a hypoxic environment inside of a tumor for several days, which highlights the potential for the development of a genetically encoded multimodal imaging probe to monitor the progress of the tumor. Here, we developed bimodal imaging tumor-homing bacteria (GVs-miRFP680 MG1655) that allow both optical and acoustic imaging in tumor-bearing mice. An in vivo optical image system and a Vevo 2100 imaging system were applied to detect different imaging properties of the engineered bacteria in vivo. Our results show that the GVs-miRFP680 MG1655 bacteria can effectively integrate the advantages of low tissue absorbance from near-infrared fluorescent proteins and non-invasiveness from gas vesicles. We successfully developed GVs-miRFP680 MG1655 bacteria, which have both acoustic and optical imaging abilities in vitro and in vivo. The acoustic signal can last for up to 25 min, while the near-infrared fluorescence signal can last for up to 96 h. The combination of different imaging modalities in the tumor-homing bacteria may contribute to the non-invasive monitoring of the therapeutic effect of bacterial therapy in the future.
first_indexed 2024-03-09T22:50:11Z
format Article
id doaj.art-47b510d1ddcc412bb6bfe50a5f3df3bd
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T22:50:11Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-47b510d1ddcc412bb6bfe50a5f3df3bd2023-11-23T18:20:52ZengMDPI AGPharmaceutics1999-49232022-08-01149180410.3390/pharmaceutics14091804Bimodal Imaging of Tumors via Genetically Engineered <i>Escherichia coli</i>Linlin Zhang0Yuanyuan Wang1Dengjin Li2Liang Wang3Zhenzhou Li4Fei Yan5Department of Ultrasound, The Second People’s Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen 518061, ChinaCenter for Cell and Gene Circuit Design, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, ChinaCenter for Quantitative Synthetic Biology, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, ChinaResearch Laboratory for Biomedical Optics and Molecular Imaging, CAS Key Laboratory of Health Informatics, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, ChinaDepartment of Ultrasound, The Second People’s Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen 518061, ChinaCenter for Cell and Gene Circuit Design, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, ChinaAlthough there are emerging innovations of molecular imaging probes to detect and image tumors, most of these molecular dyes and nanoparticles have limitations of low targetability in tumors and fast clearance when administered systemically. In contrast, some bacteria, such as <i>Escherichia coli MG1655</i>, can selectively proliferate in a hypoxic environment inside of a tumor for several days, which highlights the potential for the development of a genetically encoded multimodal imaging probe to monitor the progress of the tumor. Here, we developed bimodal imaging tumor-homing bacteria (GVs-miRFP680 MG1655) that allow both optical and acoustic imaging in tumor-bearing mice. An in vivo optical image system and a Vevo 2100 imaging system were applied to detect different imaging properties of the engineered bacteria in vivo. Our results show that the GVs-miRFP680 MG1655 bacteria can effectively integrate the advantages of low tissue absorbance from near-infrared fluorescent proteins and non-invasiveness from gas vesicles. We successfully developed GVs-miRFP680 MG1655 bacteria, which have both acoustic and optical imaging abilities in vitro and in vivo. The acoustic signal can last for up to 25 min, while the near-infrared fluorescence signal can last for up to 96 h. The combination of different imaging modalities in the tumor-homing bacteria may contribute to the non-invasive monitoring of the therapeutic effect of bacterial therapy in the future.https://www.mdpi.com/1999-4923/14/9/1804<i>Escherichia coli</i>bimodal imagingacoustic imagingoptical imagingbioluminescenceplasmid construction
spellingShingle Linlin Zhang
Yuanyuan Wang
Dengjin Li
Liang Wang
Zhenzhou Li
Fei Yan
Bimodal Imaging of Tumors via Genetically Engineered <i>Escherichia coli</i>
Pharmaceutics
<i>Escherichia coli</i>
bimodal imaging
acoustic imaging
optical imaging
bioluminescence
plasmid construction
title Bimodal Imaging of Tumors via Genetically Engineered <i>Escherichia coli</i>
title_full Bimodal Imaging of Tumors via Genetically Engineered <i>Escherichia coli</i>
title_fullStr Bimodal Imaging of Tumors via Genetically Engineered <i>Escherichia coli</i>
title_full_unstemmed Bimodal Imaging of Tumors via Genetically Engineered <i>Escherichia coli</i>
title_short Bimodal Imaging of Tumors via Genetically Engineered <i>Escherichia coli</i>
title_sort bimodal imaging of tumors via genetically engineered i escherichia coli i
topic <i>Escherichia coli</i>
bimodal imaging
acoustic imaging
optical imaging
bioluminescence
plasmid construction
url https://www.mdpi.com/1999-4923/14/9/1804
work_keys_str_mv AT linlinzhang bimodalimagingoftumorsviageneticallyengineerediescherichiacolii
AT yuanyuanwang bimodalimagingoftumorsviageneticallyengineerediescherichiacolii
AT dengjinli bimodalimagingoftumorsviageneticallyengineerediescherichiacolii
AT liangwang bimodalimagingoftumorsviageneticallyengineerediescherichiacolii
AT zhenzhouli bimodalimagingoftumorsviageneticallyengineerediescherichiacolii
AT feiyan bimodalimagingoftumorsviageneticallyengineerediescherichiacolii